T. Xia

发表

SU‐E‐T‐784: Automated VMAT Treatment Planning for Stage III Lung Cancer: How Does It Compare with IMRT?

Joe Y. Chang, Xiaodong Zhang, P. Balter, 2011 .

Promising Clinical Outcome With Long Term Follow-Up After Body Gamma Knife Stereotactic Radiosurgery for Patients With Early Stage Non-small Cell Lung Cancer

Ping Li, Xuan Wang, T. Xia, 2018, Front. Oncol..

[A randomized phase I/II trial to compare weekly usage with triple weekly usage of paclitaxel in concurrent radiochemotherapy for patients with locally advanced non-small cell lung cancer].

T. Xia, A. Shi, R. Yu, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

The application of gamma stereotactic body radiation therapy in stage I/II non-small-cell lung cancer. Promising and encouraging outcome.

Ping Li, Xuan Wang, T. Xia, 2013, Saudi medical journal.

Double CT imaging can measure the respiratory movement of small pulmonary tumors during stereotactic ablative radiotherapy.

T. Xia, G. Shen, Junliang Wang, 2012, Journal of thoracic disease.

Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation

Ping Li, Xuan Wang, T. Xia, 2020, BioMed research international.

miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway.

T. Xia, Li Ping, Hong-qi Li, 2015, International journal of radiation oncology, biology, physics.

Outcome Study of Cobalt Based Stereotactic Body Radiation Therapy for Patients with Inoperable Stage III Non-small Cell Lung Cancer

Ping Li, T. Xia, Hong-qi Li, 2015, Technology in cancer research & treatment.

Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer

Tao Zhang, W. Fang, F. Jiao, 2022, Journal of the National Cancer Center.

Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy

M. Hiraoka, T. Xia, Q. Sun, 2001, International Journal of Clinical Oncology.

Erlotinib vs etoposide/cisplatin with radiotherapy in unresectable stage III epidermal growth factor receptor mutation-positive non-small-cell lung cancer: A multicenter, randomized, open-label, phase 2 trial.

Jinming Yu, Gang Wu, Ming Chen, 2020, International journal of radiation oncology, biology, physics.

Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.

Liyuan Liu, Ping Li, Xuan Wang, 2011, International journal of radiation oncology, biology, physics.

Improved Clinical Outcome After Total Marrow Irradiation Conditioning Stem Cell Transplantation for Hematologic Malignancies

Hu Chen, T. Xia, X. Lou, 2020 .

Evaluate Efficacy and Safety of Patients with Oligometastatic NSCLC Harboring EGFR-Unmutated Treated with Stereotactic Body Radiation Therapy

T. Xia, Jianchun Zhang, Xiangsheng Xu, 2019 .

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

Yuhchyau Chen, K. Pandya, T. Xia, 2016, Front. Oncol..

Assessing efficacy and safety of stereotactic body radiation therapy for oligometastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) wild type

T. Xia, Jianchun Zhang, Zhifei Liu, 2021, Translational cancer research.

Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma

Ping Li, T. Xia, J. Xue, 2014, La radiologia medica.

Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.

Ping Li, Joe Y. Chang, Ping Li, 2006, International journal of radiation oncology, biology, physics.

Clinical Investigation : Thoracic Cancer Automated Volumetric Modulated Arc Therapy Treatment Planning for Stage III Lung Cancer : How Does It Compare With Intensity-Modulated Radio Therapy ?

Radhe Mohan, Joe Y. Chang, Zhongxing Liao, 2012 .

A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation.

Jinming Yu, Gang Wu, Ming Chen, 2017 .

Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma

T. Xia, Xian Liu, G. Ren, 2016, OncoTargets and therapy.

Influence of computed tomography contrast agent on radiotherapy dose calculation for pancreatic carcinoma: A dosimetric study based on tomotherapy and volumetric-modulated arc therapy techniques.

T. Xia, Yingjie Wang, Wei-zhang Wu, 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway.

T. Xia, Li Ping, Hong-qi Li, 2015, International Journal of Radiation Oncology, Biology, Physics.

Influence of computed tomography contrast agent on radiotherapy dose calculation for pancreatic carcinoma: A dosimetric study based on tomotherapy and volumetric-modulated arc therapy techniques.

T. Xia, Yingjie Wang, Wei-zhang Wu, 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.